Order-of-magnitude gap: the company is already serving a demand source whose scale dwarfs its own current business
The model's full reasoning — Q2 2016 call → NOWe need to determine if management describes a mismatch of scale between the company and the demand it is already serving. The key is: management conveys that the company is currently supplying/serving/participating in something enormous relative to its own size, such that even a modest further share would make it several times bigger. And management explicitly draws that size contrast. Let's review the transcript. Yaki Faitelson and Gili Iohan speak. They talk about strong momentum, growth, market awareness, etc. They mention that the problem is big and getting bigger. They cite a study: 88% of end users access sensitive data, 62% have access to data they shouldn't, 76% experienced loss/theft. They say Varonis is uniquely positioned. They talk about ransomware driving business. They mention that they are benefiting from trends. They say "We know, that the problems we are trying to solve are bigger and getting bigger." They talk about the market forming. They say "we are owning this market." They mention that they have 4,800 customers. They talk about the sales cycle becoming more predictable. They mention that they are adding 285 new customers in a quarter. They talk about the opportunity being massive. But do they explicitly draw a contrast between the company's current size and the scale of what it already serves? They say "It’s a tremendous opportunity this 285 customers represent every customer -- every customer in the world, everybody that files an emails are important to him and has active direct can be Varonis customer." That suggests a huge addressable market, but is that a mismatch of scale? They are already inside it? They have 4,800 customers, but the market is all companies. They say "we are owning this market." But they don't explicitly say "we have only captured a tiny fraction of the market we are already serving." They talk about the market being huge, but they don't quantify their share. They mention that they are seeing more attention from decision makers. They say "We are also benefiting from trends in UBA... companies realize they need credible data... This means that more and more companies realize that they need Varonis first." That suggests they are already inside, but the contrast is not explicit.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| GDRX | GoodRx Holdings, Inc. | Q2 2022 | 2022-08-08 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| HROW | Harrow Health, Inc. | Q4 2021 | 2022-03-10 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
HROW · Q4 2021 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript shows management describing Harrow as already inside the large cataract surgery market (4.5–6 million procedures annually) with real, present-tense participation: thousands of customer relationships, shipping north of two million sterile ophthalmic units last year, and touching roughly one million cataract surgeries. They explicitly contrast this scale against 2021 revenues of $72.5 million, noting that even a modest share of the pass-through-eligible market (1 million procedures × premium pricing) would produce “a big number” and drive revenues “more than double” in the near term. They treat the current business as only the “earliest sliver” of what they are already positioned inside, with the binding question being how much of the existing flow they can capture rather than whether the flow exists. This meets both criteria. The answer is YES. The transcript shows management describing Harrow as already inside the large cataract surgery market (4.
WRBY · Q1 2024 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript explicitly states that the company is already inside the optical industry with real business (245 stores serving customers, 83% of stores offering exams, 2.36 million active customers, and growing revenue from glasses, contacts, and exams). Management then draws the size contrast directly, noting that even the longer 900-store target "would still represent a small fraction of the 45,000 optical shops in the U.S." and that over 50% of major metro areas have only one store.
HSTM · Q3 2017 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...**YES** Management describes the company already being inside a much larger flow of activity (the 80 million-person healthcare workforce, of which 4.6 million are in post-acute settings) and explicitly treats the scale mismatch as the central point. They note their strong sales team is already a “steady contributor” to 4.